Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Extensive preclinical and clinical results presented for Bayer MMP inhibitor

March 30, 1998

Protein farnesyltransferase inhibitors: preclinical studies reported at AACR

March 30, 1998

New hormonal agents discussed at cancer meeting

March 30, 1998

Preclinical and clinical results for liposomal cisplatin presented at AACR meeting

March 30, 1998

Antitumor anthracyclines prepared at Pharmacia & Upjohn

March 27, 1998

Imutec Pharma begins preclinical development of antitumor agents

March 27, 1998

Disappointing preliminary phase III results for lisofylline in BMT

March 27, 1998

FDA advisory committee recommends Taxol for new indications

March 27, 1998

New drug therapy option for colonic polyps described

March 27, 1998

Differentiation-inducing retinoyloxy(substituted)alkylene butyrates from Bar-Ilan

March 26, 1998

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...